Posted 10th January 2018 by Anna Gomez
Pathology is dealing with an area of diagnostics that is extremely variable. General pathologists are able to diagnose virtually any disease, but in rare or complex cases it is common practice to consult an expert.
Posted 3rd January 2018 by Anna Gomez
Artificial intelligence based applications are quickly improving and they are expected to be a game changer in many fields, including transportation and medicine.
Posted 11th December 2017 by Anna Gomez
It is that time of the year to celebrate the most significant breakthroughs and accomplishments in the field of digital pathology. 2017 has been an exciting year with Philips receiving FDA approval to market their IntelliSite Pathology Solution for primary diagnostic use in the US.
Posted 17th November 2017 by Anna Gomez
Pathology Departments today are faced with many challenges in regards to effectively handling their workflow. More pathologists and technologists are retiring, while demand for specialist pathologists is increasing. Hospital laboratories are being forced to consolidate services and are seeking tools that can help them effectively provide more services without impacting on patient treatment.
Posted 10th November 2017 by Anna Gomez
Open science paradigm promotes open, reproducible science through the sharing of all research processes, data, material and methods. Here, Raphaël Marée from Cytomine Scientific, discusses his thoughts on open digital pathology.
Posted 1st November 2017 by Anna Gomez
Whether in a research or clinical lab, digital pathology holds a great deal of promise for all stakeholders. Earlier this year, a digital pathology platform obtained FDA clearance for whole slide imaging, thereby increasing both awareness and applicability of digital pathology. It may, however, be difficult for hospitals and laboratories to justify the acquisition costs of digital pathology platforms if one only looks on the surface. Matt Houliston from Definiens looks at the workflow and economic benefits of adopting digital pathology beyond the perhaps more obvious clinical benefits.
Posted 20th October 2017 by Jane Williams
There has been a steady increase in the adoption of Quantitative Image Analysis (QIA) for diagnostic purposes, especially for breast biomarker testing.